These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7608949)

  • 1. Quo vadis antiviral agents for herpes, influenza and HIV?
    Oxford JS
    J Med Microbiol; 1995 Jul; 43(1):1-3. PubMed ID: 7608949
    [No Abstract]   [Full Text] [Related]  

  • 2. Antivirals 1980--an update.
    Becker Y; Hadar J
    Prog Med Virol; 1980; 26():1-44. PubMed ID: 6252572
    [No Abstract]   [Full Text] [Related]  

  • 3. [Viruses and antiviral drug resistance].
    Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
    Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
    [No Abstract]   [Full Text] [Related]  

  • 4. Aromatic sulfonic acids as viral inhibitors. Structure-activity study using rhino, adeno 3, herpes simplex, and influenza viruses.
    Akerfeldt S; Westin G; Jansson T
    J Med Chem; 1971 Jul; 14(17):595-600. PubMed ID: 4365198
    [No Abstract]   [Full Text] [Related]  

  • 5. The antiviral activity of isoprinosine.
    Gordon P; Brown ER
    Can J Microbiol; 1972 Sep; 18(9):1463-70. PubMed ID: 4341918
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
    Palù G; Loregian A
    Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral Medications, Part 1: Treating Herpes and Influenza Viruses.
    Rhea Faye D FR; Kathryn P; Donna G
    Medsurg Nurs; 2017 Jan; 26(1):47-52. PubMed ID: 30351575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of antiviral resistance among the herpesvirus group].
    Reina J
    Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
    [No Abstract]   [Full Text] [Related]  

  • 9. Future antivirals-SMi conference: latest developments in HIV, hepatitis, herpes, influenza, RSV and SARS.
    Harrison R
    IDrugs; 2004 Jan; 7(1):34-6. PubMed ID: 14968814
    [No Abstract]   [Full Text] [Related]  

  • 10. The laboratory selection of antiviral agents.
    Swallow DL; Kampfner GL
    Br Med Bull; 1985 Oct; 41(4):322-32. PubMed ID: 2996683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence and control of resistance to antiviral drugs in resistance in herpes viruses, hepatitis B virus, and HIV.
    Pillay D
    Commun Dis Public Health; 1998 Mar; 1(1):5-13. PubMed ID: 9718831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
    Lockhart SM; Salvaggio MR; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Oct; 100(10):388-95. PubMed ID: 18085096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progress on antiviral agents].
    Shigeta S
    Nihon Naika Gakkai Zasshi; 1995 Sep; 84(9):1555-8. PubMed ID: 8537767
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug resistance and influenza pandemics.
    Stilianakis NI; Perelson AS; Hayden FG
    Lancet; 2002 May; 359(9320):1862-3. PubMed ID: 12044407
    [No Abstract]   [Full Text] [Related]  

  • 15. Search for antiviral agents.
    Grunert RR
    Annu Rev Microbiol; 1979; 33():335-53. PubMed ID: 227321
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral drug resistance.
    Richman DD
    Antiviral Res; 2006 Sep; 71(2-3):117-21. PubMed ID: 16621040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral chemotherapy.
    Eggers HJ
    Infection; 1984; 12(5):313-4. PubMed ID: 6210252
    [No Abstract]   [Full Text] [Related]  

  • 18. Latency and acquired resistance--problems in chemotherapy of herpes infections.
    Darby G; Field HJ
    Pharmacol Ther; 1983; 23(2):217-51. PubMed ID: 6322214
    [No Abstract]   [Full Text] [Related]  

  • 19. [Etiotropic drug therapy of widespread and socially significant human viral infections].
    Vasil'ev AN
    Antibiot Khimioter; 2010; 55(3-4):29-34. PubMed ID: 20695206
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiviral drug resistance.
    Pillay D; Zambon M
    BMJ; 1998 Sep; 317(7159):660-2. PubMed ID: 9728000
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.